Persistence of antibodies to SARS-CoV-2 in relation to symptoms in a nationwide prospective study.

den Hartog, GercoVos, Eric R Avan den Hoogen, Lotus Lvan Boven, MichielSchepp, Rutger MSmits, Gabyvan Vliet, JeffreyWoudstra, LindeWijmenga-Monsuur, Alienke Jvan Hagen, Cheyenne C ESanders, Elisabeth A Mde Melker, Hester Evan der Klis, Fiona R Mvan Binnendijk, Robert S2021-03-082021-03-082021-02-243362475110.1093/cid/ciab172http://hdl.handle.net/10029/624750en© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.COVID-19Immunoglobulin Gavidity/maturationdecaysymptomsPersistence of antibodies to SARS-CoV-2 in relation to symptoms in a nationwide prospective study.Article1537-6591Clin Infect Dis 2021; 73(12):2155-2162